Market Cap : 24.6 B | Enterprise Value : 30.36 B | PE Ratio : 107.54 | PB Ratio : 2.03 |
---|
NYSE:ZBH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:ZBH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Zimmer Biomet Holdings has the Financial Strength Rank of 5.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.Zimmer Biomet Holdings's Interest Coverage for the quarter that ended in Jun. 2022 was 8.64. Zimmer Biomet Holdings's debt to revenue ratio for the quarter that ended in Jun. 2022 was 0.86. As of today, Zimmer Biomet Holdings's Altman Z-Score is 2.74.
For the Medical Devices subindustry, Zimmer Biomet Holdings's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Financial Strength distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's Financial Strength falls into.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Zimmer Biomet Holdings's Interest Expense for the months ended in Jun. 2022 was $-39 Mil. Its Operating Income for the months ended in Jun. 2022 was $335 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $5,300 Mil.
Zimmer Biomet Holdings's Interest Coverage for the quarter that ended in Jun. 2022 is
Interest Coverage | = | -1 | * | Operating Income (Q: Jun. 2022 ) | / | Interest Expense (Q: Jun. 2022 ) |
= | -1 | * | 335.4 | / | -38.8 | |
= | 8.64 |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Zimmer Biomet Holdings's Debt to Revenue Ratio for the quarter that ended in Jun. 2022 is
Debt to Revenue Ratio | = | Total Debt (Q: Jun. 2022 ) | / | Revenue | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Revenue | |
= | (851.9 | + | 5299.6) | / | 7127.2 | |
= | 0.86 |
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Zimmer Biomet Holdings has a Z-score of 2.74, indicating it is in Grey Zones. This implies that Zimmer Biomet Holdings is in some kind of financial stress. If it is below 1.81, the company may faces bankrupcy risk.
Warning Sign:
Altman Z-score of 2.74 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.
Zimmer Biomet Holdings has the Financial Strength Rank of 5.
Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
Stellato Paul A | officer: VP, Controller & CAO | C/O XYLEM INC 1 INTERNATIONAL DRIVE RYE BROOK NY 10573 |
Van Zuilen Wilfred | officer: Pres, Europe, M. East & Africa | 345 E. MAIN STREET WARSAW IN 46580 |
Winkler Lori | officer: SVP and CHRO | 345 E. MAIN STREET WARSAW IN 46580 |
Kolli Sreelakshmi | director | C/O ALIGN TECHNOLOGY INC. 2820 ORCHARD PARKWAY SAN JOSE CA 94131 |
Ellingson Rachel | officer: SVP & CSO | 345 E MAIN STREET WARSAW K7 46580 |
Nichol Carrie Ann | officer: VP, Controller & CAO | 927 GRANDVIEW DRIVE EXTON PA 19341 |
Upadhyay Suketu | officer: Exec. VP, CFO | 345 E. MAIN STREET WARSAW IN 46580 |
Tornos Ivan | officer: Group President, Orthopedics | 345 E. MAIN STREET WARSAW IN 46580 |
Deltort Didier | officer: President, EMEA | 345 E. MAIN STREET WARSAW IN 46580 |
Hilado Maria Teresa | director | 1200 WILLOW LAKE BLVD. P.O.BOX 64683 ST. PAUL MN 55110 |
Jafry Syed A. | director | 345 E. MAIN STREET WARSAW IN 46580 |
Bruneau Aure | officer: Group President | 345 E. MAIN STREET WARSAW IN 46580 |
Hanson Bryan C | director, officer: President and CEO | ZIMMER BIOMET HOLDINGS 345 E. MAIN STREET WARSAW IN 46580 |
Delp Robert D. | officer: President, Americas | 345 EAST MAIN STREET WARSAW IN 46580 |
Schwarzman Stephen A | 10 percent owner | C/O BLACKSTONE INC. 345 PARK AVE NEW YORK NY 10154 |
Other Sources
By tipranks.com 2022-02-07
By Zacks 2022-01-28
By Zacks 2022-04-04
By Zacks 2021-11-03
By tipranks.com 2022-02-07
By tipranks.com 2022-02-07
By Seekingalpha 2022-02-07
By Zacks 2022-02-07
By Seekingalpha 2021-11-04
By Zacks 2021-12-27
By Seekingalpha 2022-02-12
By Zacks 2022-01-26
By tipranks.com 2022-02-11
By Zacks 2021-11-09